var data={"title":"Mechanisms of glomerular hyperfiltration in diabetes mellitus","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Mechanisms of glomerular hyperfiltration in diabetes mellitus</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/mechanisms-of-glomerular-hyperfiltration-in-diabetes-mellitus/contributors\" class=\"contributor contributor_credentials\">George L Bakris, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a href=\"https://www.uptodate.com/contents/mechanisms-of-glomerular-hyperfiltration-in-diabetes-mellitus/contributors\" class=\"contributor contributor_credentials\">Richard J Glassock, MD, MACP</a></dd><dd><a href=\"https://www.uptodate.com/contents/mechanisms-of-glomerular-hyperfiltration-in-diabetes-mellitus/contributors\" class=\"contributor contributor_credentials\">David M Nathan, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/mechanisms-of-glomerular-hyperfiltration-in-diabetes-mellitus/contributors\" class=\"contributor contributor_credentials\">John P Forman, MD, MSc</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/mechanisms-of-glomerular-hyperfiltration-in-diabetes-mellitus/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Jun 30, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A 25 to 50 percent elevation in the glomerular filtration rate (GFR) is seen early in the course in up to one-half of patients with type 1 diabetes mellitus [<a href=\"https://www.uptodate.com/contents/mechanisms-of-glomerular-hyperfiltration-in-diabetes-mellitus/abstract/1\" class=\"abstract_t\">1</a>], an abnormality that is exaggerated after ingestion of a protein load [<a href=\"https://www.uptodate.com/contents/mechanisms-of-glomerular-hyperfiltration-in-diabetes-mellitus/abstract/2\" class=\"abstract_t\">2</a>]. Glomerular hypertrophy and increased renal size typically accompany the rise in GFR [<a href=\"https://www.uptodate.com/contents/mechanisms-of-glomerular-hyperfiltration-in-diabetes-mellitus/abstract/2\" class=\"abstract_t\">2</a>].</p><p>Hyperfiltration also occurs early in the course of type 1 and type 2 diabetes [<a href=\"https://www.uptodate.com/contents/mechanisms-of-glomerular-hyperfiltration-in-diabetes-mellitus/abstract/3,4\" class=\"abstract_t\">3,4</a>]. In an original report of 110 newly diagnosed patients with type 2 diabetes mellitus, for example, the GFR was above 140 <span class=\"nowrap\">mL/min</span> in 16 percent and more than two standard deviations above the mean of a control population in 45 percent [<a href=\"https://www.uptodate.com/contents/mechanisms-of-glomerular-hyperfiltration-in-diabetes-mellitus/abstract/3\" class=\"abstract_t\">3</a>]. The prevalence of hyperfiltration may be lower in the era of more aggressive glucose control. A later study of 93 newly diagnosed patients, for example, found that 17 percent had a GFR that was more than two standard deviations above the mean of a control population [<a href=\"https://www.uptodate.com/contents/mechanisms-of-glomerular-hyperfiltration-in-diabetes-mellitus/abstract/5\" class=\"abstract_t\">5</a>].</p><p>The degree of hyperfiltration and the course of the GFR in type 2 diabetes mellitus was evaluated in more detail in a study of 194 Pima Indians who had GFR measured using iothalamate clearance [<a href=\"https://www.uptodate.com/contents/mechanisms-of-glomerular-hyperfiltration-in-diabetes-mellitus/abstract/4\" class=\"abstract_t\">4</a>]. The following results were noted:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In 31 patients with a normal glucose tolerance test, the mean GFR was 123 <span class=\"nowrap\">mL/min</span>.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In 29 patients with impaired glucose tolerance, the mean GFR was 135 <span class=\"nowrap\">mL/min</span>.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In 30 patients with newly diagnosed type 2 disease, the mean GFR was 143 <span class=\"nowrap\">mL/min</span>.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In 70 patients with overt diabetes for more than five years and either normal albumin excretion or moderately increased albuminuria (formerly called &quot;microalbuminuria&quot;), the mean GFR was 153 <span class=\"nowrap\">mL/min;</span> in 34 similar patients with overt proteinuria, the mean GFR was 124 <span class=\"nowrap\">mL/min</span>.</p><p/><p>After four years of follow-up, the GFR rose 14 percent in patients with impaired glucose tolerance, 18 percent in newly diagnosed patients, was stable in those with moderately increased albuminuria, and fell 35 percent in those with overt proteinuria. The rate of fall in GFR in the last group was 0.93 <span class=\"nowrap\">mL/min</span> per month, a rate similar to that seen in type 2 diabetes with overt proteinuria.</p><p>These hemodynamic and structural changes may be important clinically because intraglomerular hypertension (which is responsible for part of the rise in GFR) and glomerular hypertrophy (which increases shear stress on the glomerular capillary wall) may play an important role in the development and progression of diabetic nephropathy [<a href=\"https://www.uptodate.com/contents/mechanisms-of-glomerular-hyperfiltration-in-diabetes-mellitus/abstract/6\" class=\"abstract_t\">6</a>]. (See <a href=\"topic.htm?path=overview-of-diabetic-nephropathy\" class=\"medical medical_review\">&quot;Overview of diabetic nephropathy&quot;</a>.)</p><p>Measurement of GFR is usually required to detect hyperfiltration because estimation equations, such as the Modification of Diet in Renal Disease (MDRD) study equation, usually underestimate the true GFR when it is normal or above normal. (See <a href=\"topic.htm?path=assessment-of-kidney-function\" class=\"medical medical_review\">&quot;Assessment of kidney function&quot;</a> and <a href=\"topic.htm?path=assessment-of-kidney-function#H6\" class=\"medical medical_review\">&quot;Assessment of kidney function&quot;, section on 'Estimation of GFR'</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">MECHANISM</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Studies in experimental animals indicate that dilatation of the afferent (precapillary) glomerular arteriole plays an important role in the hyperfiltration response, by raising both the intraglomerular pressure and renal blood flow [<a href=\"https://www.uptodate.com/contents/mechanisms-of-glomerular-hyperfiltration-in-diabetes-mellitus/abstract/1\" class=\"abstract_t\">1</a>]. Why these hemodynamic changes occur is not well understood, but the following factors appear to contribute.</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h2\">Hormones</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A role for hormones is suggested by the ability of a chronic infusion of a somatostatin analogue (<a href=\"topic.htm?path=octreotide-drug-information\" class=\"drug drug_general\">octreotide</a>) to partially reverse both the early hyperfiltration and the increase in renal size in type 1 diabetic patients [<a href=\"https://www.uptodate.com/contents/mechanisms-of-glomerular-hyperfiltration-in-diabetes-mellitus/abstract/7\" class=\"abstract_t\">7</a>]. In this study, glucose control and plasma glucagon and growth hormone levels were unchanged. There was, however, a fall in the plasma concentration of insulin-like growth factor 1 (IGF1), which is produced, in part, within the kidney.</p><p>Although the pathogenetic role of IGF1 is unproven, it is of interest that infusion of this hormone in normal subjects can replicate the findings seen in diabetics: renal vasodilatation and an elevation in glomerular filtration rate (GFR) [<a href=\"https://www.uptodate.com/contents/mechanisms-of-glomerular-hyperfiltration-in-diabetes-mellitus/abstract/8\" class=\"abstract_t\">8</a>]. Similar hemodynamic changes plus renal hypertrophy can be induced by IGF1 in experimental animals [<a href=\"https://www.uptodate.com/contents/mechanisms-of-glomerular-hyperfiltration-in-diabetes-mellitus/abstract/9\" class=\"abstract_t\">9</a>].</p><p>In addition to IGF1 and other hormones, atrial natriuretic peptide had been postulated to contribute to hyperfiltration, but this is unproven [<a href=\"https://www.uptodate.com/contents/mechanisms-of-glomerular-hyperfiltration-in-diabetes-mellitus/abstract/10,11\" class=\"abstract_t\">10,11</a>]. Volume expansion due to increased sodium reabsorption may trigger its secretion, which can result in dilation of the afferent arteriole. (See <a href=\"#H6\" class=\"local\">'Increased sodium reabsorption and tubuloglomerular feedback'</a> below.)</p><p>Sex hormones may affect the degree of glomerular hyperfiltration. In one study, females had a reduction in renal plasma flow and renal blood flow and decreased renal vascular resistance in response to hyperglycemia, but no change was detected in males [<a href=\"https://www.uptodate.com/contents/mechanisms-of-glomerular-hyperfiltration-in-diabetes-mellitus/abstract/12\" class=\"abstract_t\">12</a>]. With angiotensin-converting enzyme (ACE) inhibition, both genders had a reduction in arterial pressure, but only females exhibited reduction in GFR.</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h2\">Sorbitol</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Several other factors directly related to hyperglycemia also may be important, including the intracellular accumulation of <a href=\"topic.htm?path=sorbitol-drug-information\" class=\"drug drug_general\">sorbitol</a> and the formation of glycosylated proteins. The enzyme aldose reductase converts intracellular glucose to sorbitol, which then accumulates within the cells. Studies in hyperfiltering humans with type 1 diabetes have shown that the chronic administration of an aldose reductase inhibitor (tolrestat) lowers the GFR toward normal. In one study of patients who also had moderately increased albuminuria (formerly called &quot;microalbuminuria&quot;), for example, the GFR fell from 156 to 124 <span class=\"nowrap\">mL/min</span> and albumin excretion fell from 197 to 158 <span class=\"nowrap\">mg/day</span> after six months of tolrestat [<a href=\"https://www.uptodate.com/contents/mechanisms-of-glomerular-hyperfiltration-in-diabetes-mellitus/abstract/13\" class=\"abstract_t\">13</a>]. The possible efficacy of this regimen to prevent diabetic nephropathy remains to be determined.</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h2\">Glycation products</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In chronic hyperglycemia, some of the excess circulating glucose combines with free amino acids on circulating or tissue proteins. This nonenzymatic process initially forms reversible early glycation products and later irreversible advanced glycation end products, which may accumulate in tissues and contribute to the renal and microvascular complications of diabetes (<a href=\"image.htm?imageKey=ENDO%2F80716\" class=\"graphic graphic_figure graphicRef80716 \">figure 1</a>) [<a href=\"https://www.uptodate.com/contents/mechanisms-of-glomerular-hyperfiltration-in-diabetes-mellitus/abstract/14\" class=\"abstract_t\">14</a>]. (See <a href=\"topic.htm?path=overview-of-diabetic-nephropathy\" class=\"medical medical_review\">&quot;Overview of diabetic nephropathy&quot;</a>.)</p><p>In normal rats, the infusion of early glycation products to achieve plasma concentrations similar to that seen in diabetic rats can induce the increases in renal plasma flow, GFR, and intraglomerular pressure typical of untreated diabetes [<a href=\"https://www.uptodate.com/contents/mechanisms-of-glomerular-hyperfiltration-in-diabetes-mellitus/abstract/15\" class=\"abstract_t\">15</a>]. The applicability of this observation to humans is at present unproven.</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h2\">Increased sodium reabsorption and tubuloglomerular feedback</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Enhanced tubular sodium reabsorption, due to augmented sodium-glucose cotransport, leading to extracellular fluid volume expansion may be an additional factor contributing to the rise in GFR [<a href=\"https://www.uptodate.com/contents/mechanisms-of-glomerular-hyperfiltration-in-diabetes-mellitus/abstract/1,16\" class=\"abstract_t\">1,16</a>]. Hyperinsulinemia (due to subcutaneous administration) and mild hyperglycemia can also stimulate sodium reabsorption, the latter via increased sodium-glucose cotransport in the proximal tubule [<a href=\"https://www.uptodate.com/contents/mechanisms-of-glomerular-hyperfiltration-in-diabetes-mellitus/abstract/17,18\" class=\"abstract_t\">17,18</a>]. The rise in proximal reabsorption initially decreases distal fluid delivery, which, by activating the tubuloglomerular feedback mechanism in the macula densa, can then raise the GFR via dilatation of the afferent arteriole [<a href=\"https://www.uptodate.com/contents/mechanisms-of-glomerular-hyperfiltration-in-diabetes-mellitus/abstract/17\" class=\"abstract_t\">17</a>]. Additional evidence to support this concept comes from studies using blockers of the sodium-glucose transporters in both patients with type 1 and type 2 diabetes [<a href=\"https://www.uptodate.com/contents/mechanisms-of-glomerular-hyperfiltration-in-diabetes-mellitus/abstract/19-21\" class=\"abstract_t\">19-21</a>].</p><p>The hyperfiltration in this setting is appropriate from a renal viewpoint since it counteracts the effect of enhanced proximal reabsorption, thereby returning distal sodium and water delivery toward normal and preventing excess fluid retention.</p><p class=\"headingAnchor\" id=\"H21341632\"><span class=\"h1\">SUMMARY</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Elevations in the glomerular filtration rate (GFR) are seen early in the course in many patients with diabetes mellitus. Glomerular hypertrophy and increased renal size typically accompany the rise in GFR. Intraglomerular hypertension and glomerular hypertrophy may play an important role in the development and progression of diabetic nephropathy. (See <a href=\"#H1\" class=\"local\">'Introduction'</a> above and <a href=\"topic.htm?path=overview-of-diabetic-nephropathy\" class=\"medical medical_review\">&quot;Overview of diabetic nephropathy&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Dilatation of the afferent (precapillary) glomerular arteriole plays an important role in hyperfiltration. Factors that may contribute to afferent arteriole dilatation include insulin-like growth factor 1 (IGF1), atrial natriuretic peptide, sex hormones, intracellular <a href=\"topic.htm?path=sorbitol-drug-information\" class=\"drug drug_general\">sorbitol</a>, early glycation products, and enhanced tubular sodium reabsorption in the proximal tubule. (See <a href=\"#H2\" class=\"local\">'Mechanism'</a> above.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/mechanisms-of-glomerular-hyperfiltration-in-diabetes-mellitus/abstract/1\" class=\"nounderline abstract_t\">Bank N. Mechanisms of diabetic hyperfiltration. Kidney Int 1991; 40:792.</a></li><li><a href=\"https://www.uptodate.com/contents/mechanisms-of-glomerular-hyperfiltration-in-diabetes-mellitus/abstract/2\" class=\"nounderline abstract_t\">Tuttle KR, Bruton JL, Perusek MC, et al. Effect of strict glycemic control on renal hemodynamic response to amino acids and renal enlargement in insulin-dependent diabetes mellitus. N Engl J Med 1991; 324:1626.</a></li><li><a href=\"https://www.uptodate.com/contents/mechanisms-of-glomerular-hyperfiltration-in-diabetes-mellitus/abstract/3\" class=\"nounderline abstract_t\">Vora JP, Dolben J, Dean JD, et al. Renal hemodynamics in newly presenting non-insulin dependent diabetes mellitus. Kidney Int 1992; 41:829.</a></li><li><a href=\"https://www.uptodate.com/contents/mechanisms-of-glomerular-hyperfiltration-in-diabetes-mellitus/abstract/4\" class=\"nounderline abstract_t\">Nelson RG, Bennett PH, Beck GJ, et al. Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group. N Engl J Med 1996; 335:1636.</a></li><li><a href=\"https://www.uptodate.com/contents/mechanisms-of-glomerular-hyperfiltration-in-diabetes-mellitus/abstract/5\" class=\"nounderline abstract_t\">Jin Y, Moriya T, Tanaka K, et al. Glomerular hyperfiltration in non-proteinuric and non-hypertensive Japanese type 2 diabetic patients. Diabetes Res Clin Pract 2006; 71:264.</a></li><li><a href=\"https://www.uptodate.com/contents/mechanisms-of-glomerular-hyperfiltration-in-diabetes-mellitus/abstract/6\" class=\"nounderline abstract_t\">Bakris GL, Slataper R, Vicknair N, Sadler R. ACE inhibitor mediated reductions in renal size and microalbuminuria in normotensive, diabetic subjects. J Diabetes Complications 1994; 8:2.</a></li><li><a href=\"https://www.uptodate.com/contents/mechanisms-of-glomerular-hyperfiltration-in-diabetes-mellitus/abstract/7\" class=\"nounderline abstract_t\">Serri O, Beauregard H, Brazeau P, et al. Somatostatin analogue, octreotide, reduces increased glomerular filtration rate and kidney size in insulin-dependent diabetes. JAMA 1991; 265:888.</a></li><li><a href=\"https://www.uptodate.com/contents/mechanisms-of-glomerular-hyperfiltration-in-diabetes-mellitus/abstract/8\" class=\"nounderline abstract_t\">Hirschberg R, Brunori G, Kopple JD, Guler HP. Effects of insulin-like growth factor I on renal function in normal men. Kidney Int 1993; 43:387.</a></li><li><a href=\"https://www.uptodate.com/contents/mechanisms-of-glomerular-hyperfiltration-in-diabetes-mellitus/abstract/9\" class=\"nounderline abstract_t\">Hirschberg R, Kopple JD. The growth hormone-insulin-like growth factor I axis and renal glomerular function. J Am Soc Nephrol 1992; 2:1417.</a></li><li><a href=\"https://www.uptodate.com/contents/mechanisms-of-glomerular-hyperfiltration-in-diabetes-mellitus/abstract/10\" class=\"nounderline abstract_t\">Anderson S, Vora JP. Current concepts of renal hemodynamics in diabetes. J Diabetes Complications 1995; 9:304.</a></li><li><a href=\"https://www.uptodate.com/contents/mechanisms-of-glomerular-hyperfiltration-in-diabetes-mellitus/abstract/11\" class=\"nounderline abstract_t\">Vervoort G, Veldman B, Berden JH, et al. Glomerular hyperfiltration in type 1 diabetes mellitus results from primary changes in proximal tubular sodium handling without changes in volume expansion. Eur J Clin Invest 2005; 35:330.</a></li><li><a href=\"https://www.uptodate.com/contents/mechanisms-of-glomerular-hyperfiltration-in-diabetes-mellitus/abstract/12\" class=\"nounderline abstract_t\">Cherney DZ, Sochett EB, Miller JA. Gender differences in renal responses to hyperglycemia and angiotensin-converting enzyme inhibition in diabetes. Kidney Int 2005; 68:1722.</a></li><li><a href=\"https://www.uptodate.com/contents/mechanisms-of-glomerular-hyperfiltration-in-diabetes-mellitus/abstract/13\" class=\"nounderline abstract_t\">Passariello N, Sepe J, Marrazzo G, et al. Effect of aldose reductase inhibitor (tolrestat) on urinary albumin excretion rate and glomerular filtration rate in IDDM subjects with nephropathy. Diabetes Care 1993; 16:789.</a></li><li><a href=\"https://www.uptodate.com/contents/mechanisms-of-glomerular-hyperfiltration-in-diabetes-mellitus/abstract/14\" class=\"nounderline abstract_t\">Vlassara H. Protein glycation in the kidney: role in diabetes and aging. Kidney Int 1996; 49:1795.</a></li><li><a href=\"https://www.uptodate.com/contents/mechanisms-of-glomerular-hyperfiltration-in-diabetes-mellitus/abstract/15\" class=\"nounderline abstract_t\">Sabbatini M, Sansone G, Uccello F, et al. Early glycosylation products induce glomerular hyperfiltration in normal rats. Kidney Int 1992; 42:875.</a></li><li><a href=\"https://www.uptodate.com/contents/mechanisms-of-glomerular-hyperfiltration-in-diabetes-mellitus/abstract/16\" class=\"nounderline abstract_t\">Vallon V, Blantz RC, Thomson S. Glomerular hyperfiltration and the salt paradox in early [corrected] type 1 diabetes mellitus: a tubulo-centric view. J Am Soc Nephrol 2003; 14:530.</a></li><li><a href=\"https://www.uptodate.com/contents/mechanisms-of-glomerular-hyperfiltration-in-diabetes-mellitus/abstract/17\" class=\"nounderline abstract_t\">Hannedouche TP, Delgado AG, Gnionsahe DA, et al. Renal hemodynamics and segmental tubular reabsorption in early type 1 diabetes. Kidney Int 1990; 37:1126.</a></li><li><a href=\"https://www.uptodate.com/contents/mechanisms-of-glomerular-hyperfiltration-in-diabetes-mellitus/abstract/18\" class=\"nounderline abstract_t\">Vallon V, Richter K, Blantz RC, et al. Glomerular hyperfiltration in experimental diabetes mellitus: potential role of tubular reabsorption. J Am Soc Nephrol 1999; 10:2569.</a></li><li><a href=\"https://www.uptodate.com/contents/mechanisms-of-glomerular-hyperfiltration-in-diabetes-mellitus/abstract/19\" class=\"nounderline abstract_t\">Skrti&#263; M, Yang GK, Perkins BA, et al. Characterisation of glomerular haemodynamic responses to SGLT2 inhibition in patients with type 1 diabetes and renal hyperfiltration. Diabetologia 2014; 57:2599.</a></li><li><a href=\"https://www.uptodate.com/contents/mechanisms-of-glomerular-hyperfiltration-in-diabetes-mellitus/abstract/20\" class=\"nounderline abstract_t\">Cherney DZ, Perkins BA, Soleymanlou N, et al. Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus. Circulation 2014; 129:587.</a></li><li><a href=\"https://www.uptodate.com/contents/mechanisms-of-glomerular-hyperfiltration-in-diabetes-mellitus/abstract/21\" class=\"nounderline abstract_t\">Thomas MC. Renal effects of dapagliflozin in patients with type 2 diabetes. Ther Adv Endocrinol Metab 2014; 5:53.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 3064 Version 9.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H21341632\"><span>SUMMARY</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">MECHANISM</a><ul><li><a href=\"#H3\" id=\"outline-link-H3\">Hormones</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">Sorbitol</a></li><li><a href=\"#H5\" id=\"outline-link-H5\">Glycation products</a></li><li><a href=\"#H6\" id=\"outline-link-H6\">Increased sodium reabsorption and tubuloglomerular feedback</a></li></ul></li><li><a href=\"#H21341632\" id=\"outline-link-H21341632\">SUMMARY</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"NEPH/3064|FIG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"FIGURES\">FIGURES</a></div><ul><li><a href=\"image.htm?imageKey=ENDO/80716\" class=\"graphic graphic_figure\">- Glycosylation of proteins</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=assessment-of-kidney-function\" class=\"medical medical_review\">Assessment of kidney function</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-diabetic-nephropathy\" class=\"medical medical_review\">Overview of diabetic nephropathy</a></li></ul></div></div>","javascript":null}